Could Colgate-Palmolive be headed for a break up?A Wall Street Journal report notes that an activist challenge to Colgate-Palmolive has stirred a discussion over the possibility of whether and how the consumer giant could ultimately be broken up. Walgreens-controlled VillageMD reportedly in talks to merge with Summit HealthThe value of the combined entity would be between $5 billion to $10 billion, according to a Bloomberg report. Lannett obtains FDA nod to manufacture Numbrino in Indiana The approval allows Lannett’s site in Seymour, Ind. to rapidly expand liquid drug manufacturing. Upsher-Smith adds 2 near-term generics A strategic partnership with CorePharma expands Upsher-Smith’s portfolio. State attorney generals asking Albertsons to delay $4B stockholder payout Several attorney generals sent a letter to the CEOs of Albertsons and Kroger demanding that Albertsons delay a $4 billion payout to stockholders. Lannett sells discontinued generics, inks private label deal for others Lannett's deal call for another pharmaceutical company to purchase and distribute under a private label a limited number of certain other Lannett owned generic drug products. U.S. Senators, industry orgs oppose proposed Kroger-Albertsons merger U.S. Sen. Amy Klobuchar (D-Minn.) and U.S. Sen. Mike Lee (R-Utah) announced they will hold a hearing in November to examine the proposed merger. People on the move … Oct. 19 Important personnel changes you should know this week about CVS and Pod Foods. U.S. Supreme Court rejects Novartis’ bid to prevent generic versions of Gilenya Novartis had requested the justices suspend a lower court's ruling that lifted a ban on generic versions of Gilenya. Albertsons reports strong Q2 results The retailer’s net income during the second quarter was $342.7 million compared to $295.2 million during the prior year. First Previous 56 57 58 59 60 Next Last
